14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $13.48 $17.25 Friday, 3rd May 2024 ZLAB stock ended at $16.25. This is 2.05% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.42% from a day low at $15.80 to a day high of $16.50.
90 days $13.48 $22.89
52 weeks $13.48 $39.50

Historical Zai Lab Ltd prices

Date Open High Low Close Volume
Oct 12, 2017 $35.50 $35.74 $31.56 $32.63 313 810
Oct 11, 2017 $33.70 $34.83 $32.54 $34.09 324 397
Oct 10, 2017 $30.86 $32.85 $30.45 $32.62 350 326
Oct 09, 2017 $28.39 $30.85 $28.21 $30.77 249 367
Oct 06, 2017 $26.63 $28.95 $26.63 $28.45 139 046
Oct 05, 2017 $27.16 $27.20 $26.37 $26.85 115 374
Oct 04, 2017 $27.09 $27.40 $26.88 $27.10 157 704
Oct 03, 2017 $27.05 $27.85 $26.22 $26.97 156 227
Oct 02, 2017 $26.93 $26.93 $26.20 $26.41 149 876
Sep 29, 2017 $27.15 $27.15 $26.10 $27.00 374 039
Sep 28, 2017 $26.75 $27.20 $26.75 $27.03 231 704
Sep 27, 2017 $28.09 $28.98 $27.41 $27.62 352 087
Sep 26, 2017 $27.21 $28.80 $26.73 $27.69 394 487
Sep 25, 2017 $27.61 $27.86 $26.62 $27.01 364 965
Sep 22, 2017 $31.19 $31.19 $27.10 $27.73 759 494
Sep 21, 2017 $28.18 $32.64 $28.00 $31.11 1 334 887
Sep 20, 2017 $24.25 $30.00 $23.80 $27.93 5 031 495
Click to get the best stock tips daily for free!

About Zai Lab Ltd

Zai Lab Ltd Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; and ... ZLAB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT